methyl 5-hydroxybiphenyl-2-carboxylate | 180961-91-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 5-hydroxybiphenyl-2-carboxylate
• 英文别名: methyl 5-hydroxy-1,1'-biphenyl-2-carboxylate；methyl 4-hydroxy-2-phenylbenzoate；4-Hydroxy-2-phenylbenzoic acid methyl ester
• CAS: 180961-91-5
• 化学式: C₁₄H₁₂O₃
• 分子量: 228.247
• InChiKey: NJGBHUQTURHDAK-UHFFFAOYSA-N

物化性质

• 沸点：
  418.4±38.0 °C(Predicted)
• 密度：
  1.194±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 5-hydroxybiphenyl-2-carboxylate 在 potassium carbonate 、 三乙胺 作用下， 以 四氢呋喃 、 丙酮 为溶剂， 反应 48.0h， 生成 methyl 4-<2-(imidazol-1-yl)ethoxy>-2-phenylbenzoate
  参考文献：
  名称：

  Potent, Highly Selective, and Non-Thiol Inhibitors of Protein Geranylgeranyltransferase-I

  摘要：

  The design, synthesis, and biological evaluation of a family of peptidomimetic inhibitors of protein geranylgeranyltransferase-I (PGGTase-I) are reported. The inhibitors are based on the C-terminal CAAL sequence of many geranylgeranylated proteins. Using 2-aryl-4-aminobenzoic acid derivatives as mimetics for the central dipeptide (AA), we have attached a series of imidazole and pyridine derivatives to the N-terminus as cysteine replacements. These non-thiol-containing peptidomimetics show exceptional selectivity for PGGTase-I over the closely related enzyme protein farnesyltransferase (PFTase). This selectivity is retained in whole cells where the inhibitors were shown to block the geranylgeranylation of Rap-1A without affecting the farnesylation of small GTP-binding proteins such as Ras.

  DOI：

  10.1021/jm9900873
• 作为产物：
  描述：

  4-甲氧基水杨酸甲酯 在 吡啶 、 四(三苯基膦)钯 、 三氯化铝 、 potassium carbonate 、 乙硫醇 作用下， 以 二氯甲烷 、 N,N-二甲基甲酰胺 为溶剂， 反应 29.5h， 生成 methyl 5-hydroxybiphenyl-2-carboxylate
  参考文献：
  名称：

  Potent, Highly Selective, and Non-Thiol Inhibitors of Protein Geranylgeranyltransferase-I

  摘要：

  The design, synthesis, and biological evaluation of a family of peptidomimetic inhibitors of protein geranylgeranyltransferase-I (PGGTase-I) are reported. The inhibitors are based on the C-terminal CAAL sequence of many geranylgeranylated proteins. Using 2-aryl-4-aminobenzoic acid derivatives as mimetics for the central dipeptide (AA), we have attached a series of imidazole and pyridine derivatives to the N-terminus as cysteine replacements. These non-thiol-containing peptidomimetics show exceptional selectivity for PGGTase-I over the closely related enzyme protein farnesyltransferase (PFTase). This selectivity is retained in whole cells where the inhibitors were shown to block the geranylgeranylation of Rap-1A without affecting the farnesylation of small GTP-binding proteins such as Ras.

  DOI：

  10.1021/jm9900873

文献信息

• Aminoalcohol derivatives
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：US20040006143A1

  公开（公告）日：2004-01-08

  The present invention relates to a compound formula [I]: 1 wherein 2 Y is bond, —O—(CH 2 ) n — (in which n is 1, 2, 3 or 4), etc., Z is cyano, tetrazolyl, etc., R 1 is hydrogen, lower alkyl, etc., R 2 is hydrogen or an amino protective group, R 3 is hydrogen or lower alkyl, R 4 is hydrogen or lower alkyl, R 5 and R 8 are each independently hydrogen, halogen, hydroxy, lower alkyl, etc., R 6 is hydrogen, lower alkyl, etc., R 9 is hydrogen or lower alkyl, and i is 1 or 2, or a salt thereof. The compound [I] of the present invention and pharmaceutically acceptable salts thereof are useful for the prophylactic and/or the therapeutic treatment of pollakiurea or urinary incontinence.

  本发明涉及一种化合物公式[I]: 1 其中 2 Y是键，—O—(CH 2 ) n — (其中n是1、2、3或4)，等等， Z是氰基，四唑基，等等， R 1 是氢，低级烷基，等等， R 2 是氢或氨基保护基团， R 3 是氢或低级烷基， R 4 是氢或低级烷基， R 5 和R 8 各自独立是氢，卤素，羟基，低级烷基，等等， R 6 是氢，低级烷基，等等， R 9 是氢或低级烷基，以及 i是1或2， 或其盐。本发明的化合物[I]及其药用可接受的盐对于预防性和/或治疗性治疗尿频或尿失禁是有用的。
• Inhibitors of protein isoprenyl transferases
  申请人：University of Pittsburgh

  公开号：US20020193596A1

  公开（公告）日：2002-12-19

  Compounds having the formula 1 or a pharmaceutically acceptable salt thereof wherein R 1 is (a) hydrogen, (b) loweralkyl, (c) alkenyl, (d) alkoxy, (e) thioalkoxy, (f) halo, (g) haloalkyl, (h) aryl-L 2 —, and (i) heterocyclic-L 2 —; R 2 is selected from (a) 2 (b) —C(O)NH—CH(R 14 )—C(O)OR 15 , (c) 3 (d) —C(O)NH—CH(R 14 )—C(O)NHSO 2 R 16 (e) —C(O)NH—CH(R 14 )-tetrazolyl, (f) —C(O)NH-heterocyclic, and (g) —C(O)NH—CH(R 14 )—C(O)NR 17 R 18 ; R 3 is heterocyclic, aryl, substituted or unsubstituted cycloalkyl; R 4 is hydrogen, lower alkyl, haloalkyl, halogen, aryl, arylakyl, heterocyclic, or (heterocyclic)alkyl; L 1 is absent or is selected from (a) —L 4 —N(R 5 )—L 5 —, (b) —L 4 —O—L 5 —, (c) —L 4 —S(O) n —L 5 — (d) —L 4 -L 6 —C(W)—N(R 5 )—L 5 —, (e) —L 4 -L 6 —S(O) m —N(R 5 )—L 5 —, (f) —L 4 —N(R 5 )—C(W)—L 7 -L 5 —, (g) —L 4 —N(R 5 )—S(O) p —L 7 —L 5 —, (h) optionally substituted alkylene, (i) optionally substituted alkenylene, and (j) optionally substituted alkynylene are inhibitors of protein isoprenyl transferases. Also disclosed are protein isoprenyl transferase inhibiting compositions and a method of inhibiting protein isoprenyl transferases.

  具有以下公式的化合物或其药学上可接受的盐，其中R1为(a)氢，(b)较低的烷基，(c)烯基，(d)烷氧基，(e)硫代烷氧基，(f)卤素，(g)卤代烷基，(h)芳基-L2—，以及(i)杂环-L2—；R2从(a)中选择，(b) -C(O)NH-CH(R14)-C(O)OR15，(c)中选择，(d) -C(O)NH-CH(R14)-C(O)NHSO2R16，(e) -C(O)NH-CH(R14)-四唑基，(f) -C(O)NH-杂环，以及(g) -C(O)NH-CH(R14)-C(O)NR17R18；R3为杂环，芳基，取代或未取代的环烷基；R4为氢，较低烷基，卤代烷基，卤素，芳基，芳基烷基，杂环基，或(杂环)烷基；L1为空缺或从(a) -L4-N(R5)-L5-，(b) -L4-O-L5-，(c) -L4-S(O)n-L5-，(d) -L4-L6-C(W)-N(R5)-L5-，(e) -L4-L6-S(O)m-N(R5)-L5-，(f) -L4-N(R5)-C(W)-L7-L5-，(g) -L4-N(R5)-S(O)p-L7-L5-，(h)可选择取代的烷基，(i)可选择取代的烯基，以及(j)可选择取代的炔基是蛋白异戊二烯转移酶的抑制剂。还公开了蛋白异戊二烯转移酶抑制组合物和抑制蛋白异戊二烯转移酶的方法。
• Scalable Multicomponent Synthesis of (Hetero)aryl-Substituted Phenyls: Focus on Metal-Free Halogenated Biaryls, 3-Arylindoles, and Isourolithine A Synthesis
  作者：Andrea Temperini、Daniela Lanari、Francesco Colognese、Francesca Piazzolla

  DOI：10.1002/ejoc.201901551

  日期：2019.12.19

  A simple, scalable and metal‐free multicomponent enol acetylation of (hetero)arylidene acetones followed by a thermal Diels‐Alder reaction with methyl propiolate was accomplished in a pressure metal vessel. Aromatization of the cycloadduct intermediates yielded the corresponding functionalised (hetero)biaryls.

  在压力金属容器中完成了（杂）亚芳基丙酮的简单，可扩展且无金属的多组分烯醇乙酰化反应，然后与丙酸甲酯进行了Diels-Alder热反应。环加合物中间体的芳构化得到相应的官能化的（杂）联芳基。
• Synthesis of Phenolic Biaryls and p-Terphenyls and Their Heteroaromatic Analogs via a Cycloaddition Route Using 4-Aryl-2-silyloxybuta-1,3-dienes and Electron-Deficient Alkynes
  作者：Yoshihiko Yamamoto、Keiko Nunokawa、Masatomi Ohno、Shoji Eguchi

  DOI：10.1055/s-1996-4323

  日期：1996.8

  A one-pot synthesis of phenolic biaryls and p-terphenyls by a [4+2] cycloaddition of 4-aryl-2-silyloxybuta-1,3-dienes with electron-deficient alkynes followed by oxidative aromatization of the resulting cycloadducts is reported.

  报告了通过 4-芳基-2-硅氧基丁-1,3-二烯与缺电子炔的[4+2]环加成，然后对生成的环加成物进行氧化芳香化，一步合成酚类双芳基和对三联苯的方法。
• Stable, aqueous alfa interferon solution formulations
  申请人：SCHERING CORPORATION

  公开号：EP0970703A1

  公开（公告）日：2000-01-12

  Stable aqueous solution formulations containing alfa-type interferon, e.g., interferon alfa-2a and interferon alfa-2b, a buffer to maintain the pH in the range of 4.5-7.1, polysorbate 80 as a stabilizer, edetate disodium as a chelating agent, sodium chloride as a tonicity agent, and m-cresol as an antimicrobial preservative and which maintain high chemical, physical and biological stability of the alfa-type interferon for an extended storage period of at least 24 months are disclosed.

  含有α型干扰素（如干扰素α-2a和干扰素α-2b）的稳定水溶液制剂本发明公开了含有α-型干扰素（如干扰素α-2a 和干扰素α-2b）、将 pH 值保持在 4.5-7.1 范围内的缓冲剂、作为稳定剂的聚山梨醇酯 80、作为螯合剂的乙二胺四乙酸二钠、作为补液剂的氯化钠和作为抗菌防腐剂的间甲酚的稳定水溶液制剂，这些制剂可在至少 24 个月的延长储存期内保持α-型干扰素的高化学、物理和生物稳定性。